The production of various pro-angiogenic molecules besides VEGF for promoting tumor angiogenesis is a challenging endeavor, thus constructing new anti-angiogenic peptides represents an interesting avenue for novel therapeutics [15]. This evidence concerns the gene VEGFA and neoplasm.